Document Detail


Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate.
MedLine Citation:
PMID:  22279179     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
TAMs, present in the tumor microenvironment, play an immunosuppressive role, leading to tumor progression and metastasis. Recently, numerous attempts have been made to switch immunosuppressive TAMs into an immunostimulatory type. Previously, we showed that a copper chelate, viz., copper N-(2-hydroxy acetophenone) glycinate [CuNG], can reprogram TAMs toward the proimmunogenic type to mount an antitumor immune response, but the underlying molecular mechanisms of skewing TAMs toward the proimmunogenic type remain elusive. Herein, we tried to explore the signaling mechanisms responsible for the reprogramming of TAMs. We observed that CuNG-induced ROS generation triggers activation of two MAPKs, i.e., p38MAPK and ERK1/2, and also causes up-regulation of intracellular glutathione. Furthermore, activation of p38 MAPK up-regulated the initial IL-12 production and the activation of ERK1/2 in tandem with GSH, found responsible for IFN-γ production by TAMs. This IFN-γ, in turn, prolonged IL-12 production and down-regulated TGF-β production and thus, plays the decisive role in CuNG-mediated reprogramming of regulatory cytokine production by TAMs. Our work highlights that ROS-mediated activation of MAPKs can convert suppressive macrophages toward the proimmunogenic type. Thus, the present study opens the possibility of targeting TAMs by the use of redox-active compounds for designing a novel, therapeutic strategy against cancer.
Authors:
Paramita Chakraborty; Shilpak Chatterjee; Avishek Ganguly; Piu Saha; Arghya Adhikary; Tanya Das; Mitali Chatterjee; Soumitra Kumar Choudhuri
Related Documents :
6788359 - In vitro cytotoxicity expressed by cells active against established tumors in vivo.
19176319 - Antigen-loaded exosomes alone induce th1-type memory through a b-cell-dependent mechanism.
22529529 - Peripheral leukocytapheresis attenuates acute lung injury induced by lipopolysaccharide...
11276199 - A fresh look at tumor immunosurveillance and immunotherapy.
16027139 - Ex vivo expanded human cd4+ regulatory nkt cells suppress expansion of tumor antigen-sp...
11267969 - Natural t-helper immunity against human papillomavirus type 16 (hpv16) e7-derived pepti...
15020059 - Differential expression of chemokines and chemokine receptors during microglial activat...
21986259 - The role of the intrinsic fas pathway in titanocene y apoptosis: the mechanism of overc...
12756749 - The response of murine macrophages to infection with yersinia pestis as revealed by dna...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-25
Journal Detail:
Title:  Journal of leukocyte biology     Volume:  -     ISSN:  1938-3673     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8405628     Medline TA:  J Leukoc Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
*Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata, India;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Com...
Next Document:  A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tube...